Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boston top stories
cancer immunotherapy
deals
fda
abbvie
abeona therapeutics
affordable care act
alnylam pharmaceuticals
amgen
astrazeneca
biogen
What
roundup
4
×
bio
nash
news
according
acquisitions
akcea
alzheimer’s
announced
approval
biogen’s
biopharmaceutical
biotech
cases
centers
ceo
cigarettes
collabs
companies
congress
control
convo
covid
daniel
deal
deaths
democrats
disease
divided
drug
earlier
elections
electronic
failures
fallout
gilead
gilead’s
help
including
injuries
Language
unset
Current search:
roundup
×
novartis
×
" clinical trials "
×
startups
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
